Infectious diseases have been a threat to human health globally. The relentless efforts and
research have enabled us to overcome most of the diseases through the use of antiviral and …

Since the declaration of COVID-19 as a pandemic in 2020, several therapies have been
developed to reduce symptoms of COVID-19 infection and prevent progression. Paxlovid is …

Patients with cancer are at increased risk of hospitalisation and mortality following severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the SARS-CoV …

The SARS-CoV-2 main protease (Mpro) is a major therapeutic target. The Mpro inhibitor,
nirmatrelvir, is the antiviral component of Paxlovid, an orally available treatment for COVID …

Azvudine (FNC) is a synthetic nucleoside analog used to treat adult patients living with
human immunodeficiency virus-1 (HIV-1) infection with high viral load. After …

During the current outbreak of the novel coronavirus disease 2019 (COVID-19), researchers
have examined several antiviral drugs with the potential to inhibit the proliferation of the …

In order to address the world-wide health challenge caused by the COVID-19 pandemic, the
3CL protease/SARS-CoV-2 main protease (SARS-CoV-2-Mpro) coded by its nsp5 gene …

The coronavirus, a subfamily of the coronavirinae family, is an RNA virus with over 40
variations that can infect humans, non-human mammals and birds. There are seven types of …

Breakthrough infections have been reported in fully vaccinated persons. Furthermore,
rebound symptoms have been reported following the new FDA granted emergency use to …

Background: Coronavirus disease (COVID-19) seriously endangers global public health.
Pupingqinghua prescription (PPQH) is an herbal formula from traditional Chinese medicine …